> The first federal trial involving Vioxx began today in Houston. The widow of a 53-year-old man says the drug was the cause of her husband's death, but Merck maintains that the husband died from heart disease. The case was moved from New Orleans to Houston after Hurricane Katrina hit. Report [1]
> Germany's Schering has started three Phase II trials to test the safety and efficacy of ZK-EPO for several types of cancer. Report [2]
> Biovail has launched its diabetes drug Glumetza in Canada. Release [3]
> Mylan has received approval for its generic version of Aventis Pharmaceuticals' Amaryl Tablets. Release [4]
And Finally… Researchers are studying a possible link between cancer and stress. Article [5]
Links:
[1] http://news.yahoo.com/s/ap/20051129/ap_on_bi_ge/vioxx_federal_trial;_ylt=Ah3gkaFo96i5zknxoQX9FhpZ24cA;_ylu=X3oDMTBiMW04NW9mBHNlYwMlJVRPUCUl
[2] http://www.forbes.com/markets/feeds/afx/2005/11/30/afx2359756.html
[3] http://www.ccnmatthews.com/news/releasesfr/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=569724
[4] http://www.drugnewswire.com/1318/
[5] http://www.nytimes.com/2005/11/29/health/29canc.html